Racial and ethnic differences in epithelial ovarian cancer risk: an analysis from the Ovarian Cancer Association Consortium
- PMID: 38775277
- PMCID: PMC11369223
- DOI: 10.1093/aje/kwae076
Racial and ethnic differences in epithelial ovarian cancer risk: an analysis from the Ovarian Cancer Association Consortium
Abstract
Limited estimates exist on risk factors for epithelial ovarian cancer (EOC) in Asian, Hispanic, and Native Hawaiian/Pacific Islander women. Participants in this study included 1734 Asian (n = 785 case and 949 control participants), 266 Native Hawaiian/Pacific Islander (n = 99 case and 167 control participants), 1149 Hispanic (n = 505 case and 644 control participants), and 24 189 White (n = 9981 case and 14 208 control participants) from 11 studies in the Ovarian Cancer Association Consortium. Logistic regression models estimated odds ratios (ORs) and 95% CIs for risk associations by race and ethnicity. Heterogeneity in EOC risk associations by race and ethnicity (P ≤ .02) was observed for oral contraceptive (OC) use, parity, tubal ligation, and smoking. We observed inverse associations with EOC risk for OC use and parity across all groups; associations were strongest in Native Hawaiian/Pacific Islander and Asian women. The inverse association for tubal ligation with risk was most pronounced for Native Hawaiian/Pacific Islander participants (odds ratio (OR) = 0.25; 95% CI, 0.13-0.48) compared with Asian and White participants (OR = 0.68 [95% CI, 0.51-0.90] and OR = 0.78 [95% CI, 0.73-0.85], respectively). Differences in EOC risk factor associations were observed across racial and ethnic groups, which could be due, in part, to varying prevalence of EOC histotypes. Inclusion of greater diversity in future studies is essential to inform prevention strategies. This article is part of a Special Collection on Gynecological Cancers.
Keywords: ethnicity; ovarian cancer; race; risk factors.
© The Author(s) 2024. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health.
Conflict of interest statement
The authors declare no conflicts of interest.
References
-
- Surveillance, Epidemiology and End Results (SEER) Program, National Cancer Institute . SEER*Stat Database: Incidence - SEER Research Data, 8 Registries, Nov 2021 Sub (1975-2019) - Linked To County Attributes - Time Dependent (1990-2019) Income/Rurality, 1969-2020 Counties. National Cancer Institute, DCCPS, Surveillance Research Program; 2022.
-
- The University of Hawai‘i Cancer Center and Hawai‘i Tumor Registry . Cancer Mortality for the State of Hawaii (1978-2012). The University of Hawai‘i Cancer Center and Hawai‘i Tumor Registry; 2015.
MeSH terms
Substances
Grants and funding
- W81XWH-10-1-02802/Department of Defense
- PPD/RPCI.07/Ovarian Cancer Research Fund
- GNT1173346/NHMRC Investigator
- R03CA115195/GF/NIH HHS/United States
- P30 CA008748/CA/NCI NIH HHS/United States
- OC200236/Department of Defense Ovarian Cancer Research Program, Ovarian Cancer Academy Early Career Investigator Award
- K07 CA095666/CA/NCI NIH HHS/United States
- R01-CA83918/CA/NCI NIH HHS/United States
- 400281/National Health and Medical Research Council of Australia
- 2II0200/California Cancer Research Program
- R01 CA058598/CA/NCI NIH HHS/United States
- DAMD17-01-1-0729/US Army Medical Research and Materiel Command
- R01-CA87538/National Institutes of Health (NIH)
- Cancer Councils of New South Wales, Victoria, Queensland, South Australia, and Tasmania; and Cancer Foundation of Western Australia
- Ovarian Cancer Australia and the Peter MacCallum Foundation
- LVS-39420/Lon V Smith Foundation
- P30 CA071789/CA/NCI NIH HHS/United States
- R01 CA112523/CA/NCI NIH HHS/United States
- P50 CA136393/CA/NCI NIH HHS/United States
